The predictive value of the systemic immune-inflammatory index for left atrial appendage thrombus in non-valvular atrial fibrillation.

OBJECTIVE The systemic immune inflammatory index (SII) has prognostic value in cardiovascular diseases. The aim of current study was to investigate whether or not left atrial appendage (LAA) thrombus could be predicted by SII in patients with non-valvular atrial fibrillation. METHOD The study included 525 patients newly diagnosed with non-valvular atrial fibrillation, who had not previously had anticoagulant treatment (50.7% male, mean age 62.94±10.79 years). All patients underwent transoesophageal echocardiography. RESULTS LAA thrombus was observed in 86 patients (16.4%). In the ROC curve SII had a good diagnostic power in predicting LAA thrombus (AUC: 0.760, 95% CI: 0.703-0.818, P<0.001). In the multivariate regression analysis, diabetes (Hazard ratio: 2.264, 95% CI: 1.169-4.389, P=0.015), LAA emptying rate of <20 cm/s (Hazard ratio: 59.347, 95% CI: 25.397-138.680, P<0.001), and SII value of >750 (Hazard ratio: 4.291, 95% CI: 2.144-8.586 P<0.001) were determined as independent predictors for LAA thrombus. A poor correlation was found between SII and the CHADS2 VASc score (r=0.239, P<0.001) Conclusion: The SII, a practical and easily obtained test, can be used as a predictor of LAA thrombus in patients with non-valvular atrial fibrillation, and to decide on the anticoagulant treatment.

[1]  I. Inanc,et al.  Systemic Immune-Inflammation Index and C-Reactive Protein/Albumin Ratio Could Predict Acute Stent Thrombosis and High SYNTAX Score in Acute Coronary Syndrome , 2022, Angiology.

[2]  Xiao Chen,et al.  The Diagnostic Value of the Systemic Immune-Inflammation Index for Venous Thromboembolism in Lung Cancer Patients: A Retrospective Study , 2022, Mediators of inflammation.

[3]  Ş. Arslan,et al.  Usefulness of systemic immune-inflammation index in predicting atrial fibrillation recurrence after direct current cardioversion. , 2022, Biomarkers in medicine.

[4]  Jintao Zhu,et al.  Systemic immune inflammation index and system inflammation response index are potential biomarkers of atrial fibrillation among the patients presenting with ischemic stroke , 2022, European Journal of Medical Research.

[5]  Shao-bo Shi,et al.  Left Atrial Thrombus in Patients With Non-valvular Atrial Fibrillation: A Cross-Sectional Study in China , 2022, Frontiers in Cardiovascular Medicine.

[6]  S. Altay,et al.  Systemic Immune-Inflammation Index: A Novel Predictor of Coronary Thrombus Burden in Patients with Non-ST Acute Coronary Syndrome , 2022, Medicina.

[7]  Fatma Kaplan Efe,et al.  The association between platelet to lymphocyte ratio and left atrial appendage thrombogenic milieu in patients with non-valvular atrial fibrillation , 2022, Ankara Medical Journal.

[8]  F. Aksoy,et al.  Systemic immune-inflammation index predicts new onset atrial fibrillation after ST elevation myocardial infarction. , 2021, Biomarkers in medicine.

[9]  Cong Jiang,et al.  Systemic Immune-Inflammation Index Is Superior to Neutrophil to Lymphocyte Ratio in Prognostic Assessment of Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy , 2020, BioMed research international.

[10]  Xingxiang Wang,et al.  Determinants of left atrial thrombus or spontaneous echo contrast in nonvalvular atrial fibrillation. , 2020, Thrombosis research.

[11]  Yenn-Jiang Lin,et al.  Systemic immune‐inflammation index (SII) predicted clinical outcome in patients with coronary artery disease , 2020, European journal of clinical investigation.

[12]  C. Yosefy,et al.  Difference in left atrial appendage remodeling between diabetic and nondiabetic patients with atrial fibrillation , 2019, Clinical Cardiology.

[13]  S. Gonçalves,et al.  A lower left atrial appendage peak emptying velocity in the acute phase of cryptogenic stroke predicts atrial fibrillation occurrence during follow‐up , 2019, Echocardiography.

[14]  W. Guo,et al.  Systemic immune-inflammation index (SII) is useful to predict survival outcomes in patients with surgically resected esophageal squamous cell carcinoma , 2019, Journal of Cancer.

[15]  Wan-Hai Wang,et al.  Prognostic value of Systemic immune-inflammation index in cancer: A meta-analysis , 2018, Journal of Cancer.

[16]  G. Lip,et al.  Role of chronic kidney disease and atrial fibrillation in outcomes of patients with ischemic stroke , 2018, European journal of neurology.

[17]  Silvia Schievano,et al.  Computational Fluid Dynamic Analysis of the Left Atrial Appendage to Predict Thrombosis Risk , 2018, fcvm.

[18]  T. Huynh,et al.  Assessment and Management of the Left Atrial Appendage Thrombus in Patients With Nonvalvular Atrial Fibrillation. , 2017, The Canadian journal of cardiology.

[19]  M. Sadowski,et al.  Left atrial appendage function assessment and thrombus identification☆ , 2016, International journal of cardiology. Heart & vasculature.

[20]  M. Yalçın,et al.  Neutrophil–Lymphocyte Ratio May Predict Left Atrial Thrombus in Patients With Nonvalvular Atrial Fibrillation , 2015, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

[21]  Reza Arsanjani,et al.  The left atrial appendage: anatomy, function, and noninvasive evaluation. , 2014, JACC. Cardiovascular imaging.

[22]  M. Yalçın,et al.  The CHA2DS2-VASc Score as a Predictor of Left Atrial Thrombus in Patients with Non-Valvular Atrial Fibrillation , 2014, Medical Principles and Practice.

[23]  Charles J Bruce,et al.  Guidelines for Performing a Comprehensive Transesophageal Echocardiographic Examination: Recommendations from the American Society of Echocardiography and the Society of Cardiovascular Anesthesiologists , 2007, Anesthesia and Analgesia.

[24]  Sanghamitra Mohanty,et al.  Does the left atrial appendage morphology correlate with the risk of stroke in patients with atrial fibrillation? Results from a multicenter study. , 2012, Journal of the American College of Cardiology.

[25]  A. Oguzhan,et al.  Relation of left atrial spontaneous echocardiographic contrast in patients with mitral stenosis to inflammatory markers. , 2012, The American journal of cardiology.

[26]  M. Ozaydın,et al.  Inflammatory markers according to types of atrial fibrillation. , 2007, International journal of cardiology.

[27]  A. Hernández Madrid,et al.  Atrial fibrillation and C-reactive protein: searching for local inflammation. , 2007, Journal of the American College of Cardiology.

[28]  G. Lip,et al.  Is atrial fibrillation an inflammatory disorder? , 2006, European heart journal.

[29]  J. Svendsen,et al.  Inflammation in the genesis and perpetuation of atrial fibrillation. , 2005, European heart journal.

[30]  J. Gardin,et al.  American Society of Echocardiography recommendations for use of echocardiography in clinical trials. , 2004, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[31]  Transesophageal Echocardiographic Correlates of Thromboembolism in High-Risk Patients with Nonvalvular Atrial Fibrillation , 1998, Annals of Internal Medicine.

[32]  A Laupacis,et al.  Prevalence, age distribution, and gender of patients with atrial fibrillation. Analysis and implications. , 1995, Archives of internal medicine.

[33]  J. Coromilas,et al.  Left atrial appendage function and thrombus formation in atrial fibrillation-flutter: a transesophageal echocardiographic study. , 1994, Journal of the American College of Cardiology.

[34]  W. Daniel,et al.  Assessment of left atrial appendage function by biplane transesophageal echocardiography in patients with nonrheumatic atrial fibrillation: identification of a subgroup of patients at increased embolic risk. , 1994, Journal of the American College of Cardiology.